eClinical Solutions Announces Growth of Clinical Data Platform and Tech-Enabled Clinical Data Services Used to Accelerate Digital Transformation

Boston-based life sciences tech innovator builds on success of its elluminate® platform and ASCEND services to accelerate clinical trials

eClinical Solutions LLC, a leading global provider of cloud-based enterprise software and software-driven clinical data services, announced increased adoption of its flagship elluminate Clinical Data Platform and its recently launched ASCEND Clinical Data Services. Numerous life sciences companies including those from large pharma, mid market and emerging biotechs joined more than 100 pharmaceutical innovators in using elluminate to unify diverse clinical data sources for real-time data visibility, transformation, and analysis.

Recommended AI News: Planful Announces Summer20 Product Release, Expands Collaboration Capabilities For Continuous Planning In All Areas Of The Business

A key driver of elluminate’s increased market adoption is industry demand for the smart data management workbench capabilities available in elluminate Data Central, which was recently recognized as winner of the Society for Clinical Data Management (SCDM)’s Pitch Arena at SCDM 2020 Virtual. At SCDM’s Pitch Arena, elluminate Data Central was chosen by the audience among six top contenders showcasing clinical technology products. And with a 40 percent increase in trial cycle times over the last two years, eClinical’s ASCEND data services support emerging and mid-market life sciences companies in addressing this trend and reducing trial inefficiencies by optimizing their clinical data.

Recommended AI News: Revbits Announces Issuance Of US Patent For Unique Product Security Architecture Using Zero-Knowledge Encryption

Clinical studies are more complex than ever, with sponsors transitioning to decentralized trials and working with an average of five diverse data sources per trial. To facilitate faster drug submissions, more sophisticated technology platforms are required to gain greater data access and control. eClinical Solutions’ elluminate platform was named in a recent report by Gartner, Hype Cycle for Life Science Research and Development, 2020* as a sample vendor under Clinical Data Analytics Platforms and a Risk-Based and Centralized Monitoring. As stated in the report, “successfully leveraging RBM tools can significantly reduce costs and optimize processes for monitoring trial sites.” The report also highlights that, Clinical Data Analytics Platforms “streamline business processes, simplify workflows, and provide advanced analytics tools, reports, and visualizations deployed on an integrated data model.”

“We are helping sponsors decrease cycle times and improve the clinical development process by providing faster access to data and automating data review,” said Raj Indupuri, eClinical Solutions’ CEO. “With increasing data complexity and industry pressures on speed to market, life sciences companies must modernize their technology infrastructure and adopt clinical data platforms like elluminate to minimize impacts on trial timelines.”

Recommended AI News: AFWERX Announces Hazardous Software Among Top Selected Teams Across The Globe Vying To Build The Base Of The Future